Prevalence of genetic prothrombotic risk factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population

Ann Hum Biol. 2015;42(6):576-80. doi: 10.3109/03014460.2014.968618. Epub 2014 Oct 30.

Abstract

Background: Venous thrombosis (VT) affects 1-2 out of 10(3) individuals each year. Mutations of 1691G > A FV gene, 20210G > A PT gene and 677C > T gene MTHFR are common in Europe and increase the risk of venous thrombosis. To the authors' knowledge, this is the first report on the prevalence of these mutations in the general population of Bosnia and Herzegovina.

Aim: The aim of this study was to simultaneously analyse main VT associated polymorphisms and compare the results with those published for other European populations.

Data sources: Electronic databases including Medline and Embase were searched from 1995 to December 2013.

Subjects and methods: The subjects of the study consisted of 100 unrelated healthy people from Bosnia and Herzegovina (82 female and 18 male). The mean age of the cohort was 58.8 (± 10.7) years. PCR-RFLP was used for measurement of allele frequencies.

Results: All three SNPs were found to be polymorphic, with allele frequencies of 6.0%, 6.0% and 37.5% for 1691A FV, 20210A PT and 677T MTHFR, respectively.

Conclusion: Further studies on larger cohorts with an adequate female-to-male ratio are necessary to confirm a high prevalence of hereditary thrombophilia in the Bosnian population.

Keywords: Allele frequency; genetic factors; population genetics; thrombophilic mutations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bosnia and Herzegovina
  • Factor V / genetics*
  • Factor V / metabolism
  • Female
  • Gene Frequency
  • Humans
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Methylenetetrahydrofolate Reductase (NADPH2) / metabolism
  • Middle Aged
  • Mutation
  • Polymorphism, Single Nucleotide*
  • Prevalence
  • Prothrombin / genetics*
  • Prothrombin / metabolism
  • Risk Factors
  • Thrombophilia / epidemiology*
  • Thrombophilia / genetics
  • Young Adult

Substances

  • Factor V
  • Prothrombin
  • Methylenetetrahydrofolate Reductase (NADPH2)

Supplementary concepts

  • Thrombophilia, hereditary